The Valley Desk

LetterAmerican journal of hematologyPublished

Lenalidomide-Dexamethasone as an Effective and Well-Tolerated Treatment Option for Refractory Rosai-Dorfman-Destombes Disease: A Clinical and Pharmacophenomic Study

Read the publication ↗

Regional connection

Verified An author affiliation on the Europe PMC record names University of Pennsylvania. Affiliation source

Publication record

Type
Letter
Venue
American journal of hematology
Published
Subject terms
Humans; Histiocytosis, Sinus; Thalidomide; Dexamethasone; Lenalidomide; Cereblon; Histiocyte; Rosai‐dorfman; Pharmacophenomics
PubMed ID
41928050
Added to directory
Source checked

Report a correction or request removal